PGC-1α:在OSA中对上呼吸道扩张器肌肉结构和功能障碍的潜在治疗标
Xing An1, Jie Zhou1, Linxi He2
1Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Sleep & breathing = Schlaf & Atmung
|October 31, 2025
概括
阻塞性睡眠呼吸暂停 (OSA) 由于线粒体功能障碍而损害上呼吸道肌肉. 准PGC-1α可能为这种疾病提供新的治疗方法.
科学领域:
- 睡眠医学 睡眠医学
- 肌肉生理学 肌肉生理学
- 线粒体生物学 线粒体生物学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 具有严重的健康负担,治疗选择有限.
- 上呼吸道扩展器肌肉功能障碍,标志着线粒体异常和纤维类型变化,是OSA的关键致病因素.
- 线粒体功能障碍会损害肌肉和神经元的能量生产,导致OSA的病原性.
研究的目的:
- 阐明氧酶增殖器激活受体马协活性剂-1α (PGC-1α) 在调节OSA上呼吸道扩张肌肉功能的核心作用.
- 审查目前针对OSA的PGC-1α治疗策略.
- 建议PGC-1α作为OSA的潜在治疗点.
主要方法:
- 关于 mitochondrial biogenesis,动力学,新陈代谢,氧化应激,炎症和运动神经元活动中的 PGC-1α 功能的文献综述.
- 对PGC-1α在OSA上呼吸道扩张肌肉结构和功能损伤中的作用的分析.
- 在OSA中针对PGC-1α的现有治疗干预措施的摘要.
主要成果:
- PGC-1α对于维护线粒体健康和上呼吸道扩张器肌肉的功能至关重要.
- 在OSA中,PGC-1α的失调有助于线粒体功能障碍,肌肉疲劳和神经损伤.
- 针对PGC-1α的现有疗法对OSA治疗有很大的前景.
结论:
- 在OSA中,PGC-1α在上呼吸道扩张器肌肉功能障碍的病理生理学中发挥着关键作用.
- 准PGC-1α代表了管理OSA的有希望的治疗途径.
- 需要进一步的研究来探索基于PGC-1α的OSA干预措施.
相关概念视频
Sleep Apnea
465
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
465
G Protein-coupled Receptors
16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K


